Caixia Dong

发表

A Patient of Advanced NSCLC with a New EGFR Exon 19 Insertion Mutation and its Response to EGFR-TKIs.

Shanshan Weng, N. Zhu, Ying Yuan, 2019, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020

Zhen Zhang, Su-zhan Zhang, Shanshan Weng, 2021, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy.

Ying Yuan, Xiao-fen Li, X. Zhong, 2014, World journal of gastroenterology.

Oncotargets and Therapy Dovepress Critical Appraisal of the Role of Gefitinib in the Management of Locally Advanced or Metastatic Non-small Cell Lung Cancer

Shanshan Weng, Ying Yuan, Jian-jin Huang, 2022 .

Epidemiological features of lung giant cell carcinoma and therapy for patients with EGFR mutations based on case reports and the surveillance, epidemiology, and end results (SEER) database

Shanshan Weng, Ying Yuan, Hong Shen, 2017, Oncotarget.

Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database

Shanshan Weng, Ying Yuan, J. Zhong, 2016, Oncotarget.

APC Promoter Methylation in Gastrointestinal Cancer

Xinyu Li, Mengyuan Yang, Ying Yuan, 2021, Frontiers in Oncology.

Prognostic and survival analysis of 837 Chinese colorectal cancer patients.

Ying Yuan, Hong Shen, Xiao-fen Li, 2013, World journal of gastroenterology.

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials

X. Fang, Ying Yuan, Dan Li, 2016, PloS one.

Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study

X. Fang, Jian Wang, Shanshan Weng, 2023, BMC Cancer.

Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial

X. Fang, Jian Wang, Hongfeng Cao, 2023, EClinicalMedicine.

The clinicopathological features and prognostic factors of gastric squamous cell carcinoma

Ying Yuan, Dan Li, Chenhan Zhong, 2016, Medicine.

Critical appraisal of the role of gefitinib in the management of locally advanced or metastatic non-small cell lung cancer

Shanshan Weng, Ying Yuan, Jian-jin Huang, 2014, OncoTargets and therapy.